- Home
- ORGN vs ADAG Comparison
ORGN vs ADAG Comparison
Compare ORGN & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGN
- ADAG
- Stock Information
- Founded
- ORGN 2008
- ADAG 2011
- Country
- ORGN United States
- ADAG China
- Employees
- ORGN 109
- ADAG N/A
- Industry
- ORGN Major Chemicals
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- ORGN Industrials
- ADAG Health Care
- Exchange
- ORGN Nasdaq
- ADAG Nasdaq
- Market Cap
- ORGN 89.9M
- ADAG 91.4M
- IPO Year
- ORGN N/A
- ADAG 2021
- Fundamental
- Price
- ORGN $0.60
- ADAG $1.75
- Analyst Decision
- ORGN Strong Buy
- ADAG Strong Buy
- Analyst Count
- ORGN 1
- ADAG 1
- Target Price
- ORGN $3.00
- ADAG $8.00
- AVG Volume (30 Days)
- ORGN 871.6K
- ADAG 109.9K
- Earning Date
- ORGN 08-13-2025
- ADAG 07-28-2025
- Dividend Yield
- ORGN N/A
- ADAG N/A
- EPS Growth
- ORGN N/A
- ADAG N/A
- EPS
- ORGN N/A
- ADAG N/A
- Revenue
- ORGN $29,887,000.00
- ADAG $103,204.00
- Revenue This Year
- ORGN $49.18
- ADAG $6,488.89
- Revenue Next Year
- ORGN $144.81
- ADAG $57.50
- P/E Ratio
- ORGN N/A
- ADAG N/A
- Revenue Growth
- ORGN N/A
- ADAG N/A
- 52 Week Low
- ORGN $0.40
- ADAG $1.33
- 52 Week High
- ORGN $1.90
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- ORGN 63.37
- ADAG 43.63
- Support Level
- ORGN $0.54
- ADAG $1.60
- Resistance Level
- ORGN $0.65
- ADAG $2.00
- Average True Range (ATR)
- ORGN 0.04
- ADAG 0.19
- MACD
- ORGN 0.01
- ADAG -0.02
- Stochastic Oscillator
- ORGN 80.90
- ADAG 30.00
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.